Cargando…

PET Imaging of Epigenetic Influences on Alzheimer's Disease

The precise role of environment-gene interactions (epigenetics) in the development and progression of Alzheimer's disease (AD) is unclear. This review focuses on the premise that radiotracer-specific PET imaging allows clinicians to visualize epigenetically influenced events and that such imagi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Couto, Paul J., Millis, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633540/ https://www.ncbi.nlm.nih.gov/pubmed/26600964 http://dx.doi.org/10.1155/2015/575078

Ejemplares similares

Epigenetics and Autism
por: Mbadiwe, Tafari, et al.
Publicado: (2013)

Epigenetics and Breast Cancers
por: Vo, An T., et al.
Publicado: (2012)

Imaging Alzheimer's disease pathophysiology with PET
por: Schilling, Lucas Porcello, et al.
Publicado: (2016)

Amyloid PET imaging: applications beyond Alzheimer’s disease
por: Catafau, Ana M., et al.
Publicado: (2015)

Epigenetics of Alzheimer’s Disease
por: Nikolac Perkovic, Matea, et al.
Publicado: (2021)

PET molecular imaging for pathophysiological visualization in Alzheimer’s disease
por: Wang, Jing, et al.
Publicado: (2022)

Novel PET/SPECT Probes for Imaging of Tau in Alzheimer's Disease
por: Watanabe, Hiroyuki, et al.
Publicado: (2015)

Epigenetic Influences on Wound Healing and Hypertrophic-Keloid Scarring: A Review for Basic Scientists and Clinicians
por: Thomas, Asia, et al.
Publicado: (2022)

PET Imaging of Neuroinflammation in Alzheimer’s Disease
por: Zhou, Rong, et al.
Publicado: (2021)

Epigenetic mechanisms in Alzheimer’s disease
por: Balazs, Robert
Publicado: (2014)

Application of Deep Learning for Prediction of Alzheimer’s Disease in PET/MR Imaging
por: Zhao, Yan, et al.
Publicado: (2023)

Epigenetic Mechanisms in Obesity: Broadening Our Understanding of the Disease
por: Smith, Erin N. L., et al.
Publicado: (2023)

PET Imaging in Animal Models of Alzheimer’s Disease
por: Chen, Baosheng, et al.
Publicado: (2022)

Tauvid™: The First FDA-Approved PET Tracer for Imaging Tau Pathology in Alzheimer’s Disease
por: Jie, Caitlin V. M. L., et al.
Publicado: (2021)

Epigenetics and Pain: New Insights to an Old Problem
por: Nirvanie-Persaud, Lisa, et al.
Publicado: (2022)

PET imaging of mGluR5 in Alzheimer’s disease
por: Mecca, Adam P., et al.
Publicado: (2020)

Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET
por: Promteangtrong, Chetsadaporn, et al.
Publicado: (2015)

PET Imaging of Tau Pathology in Alzheimer’s Disease and Tauopathies
por: James, Olga G., et al.
Publicado: (2015)

Epigenetic Modulation on Tau Phosphorylation in Alzheimer's Disease
por: Yu, Chao-Chao, et al.
Publicado: (2019)

Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment
por: Chandra, Avinash, et al.
Publicado: (2019)

Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging Perspective
por: Fontana, Igor C., et al.
Publicado: (2023)

Epigenetics of Trauma Transmission and Fetal Alcohol Spectrum Disorder: What Does the Evidence Support?
por: Orton, Sarah M., et al.
Publicado: (2023)

Epigenetics in Alzheimer’s Disease
por: Gao, Xiaodie, et al.
Publicado: (2022)

The Who, When, Why, and How of PET Amyloid Imaging in Management of Alzheimer’s Disease—Review of Literature and Interesting Images
por: Suppiah, Subapriya, et al.
Publicado: (2019)

PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease
por: Pontecorvo, Michael J, et al.
Publicado: (2011)

Possible Epigenetic Role of Vitexin in Regulating Neuroinflammation in Alzheimer's Disease
por: Yahaya, M. A. F., et al.
Publicado: (2020)

Epigenetic regulation of adult neural stem cells: implications for Alzheimer’s disease
por: Fitzsimons, Carlos P, et al.
Publicado: (2014)

Using amyloid PET imaging to diagnose Alzheimer’s disease in patients with multiple sclerosis
por: Kolanko, Magdalena, et al.
Publicado: (2020)

Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer’s Disease
por: Villa, Chiara, et al.
Publicado: (2022)

Topographical Heterogeneity of Alzheimer’s Disease Based on MR Imaging, Tau PET, and Amyloid PET
por: Jeon, Seun, et al.
Publicado: (2019)

Role of Fluid Biomarkers and PET Imaging in Early Diagnosis and its Clinical Implication in the Management of Alzheimer’s Disease
por: Hameed, Shahul, et al.
Publicado: (2020)

PET/MR Imaging: New Frontier in Alzheimer's Disease and Other Dementias
por: Zhang, Xin Y., et al.
Publicado: (2017)

PET Imaging of Neutrophils Infiltration in Alzheimer's Disease Transgenic Mice
por: Kong, Yanyan, et al.
Publicado: (2020)

The Sensitivity of Tau Tracers for the Discrimination of Alzheimer’s Disease Patients and Healthy Controls by PET
por: Mohammadi, Zohreh, et al.
Publicado: (2023)

Epigenetics of Aging and Alzheimer’s Disease: Implications for Pharmacogenomics and Drug Response
por: Cacabelos, Ramón, et al.
Publicado: (2015)

PET Imaging in Huntington’s Disease
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2015)

Epigenetic Alterations in Alzheimer’s Disease
por: Sanchez-Mut, Jose V., et al.
Publicado: (2015)

Epigenetic modifications of chronic hypoxia-mediated neurodegeneration in Alzheimer’s disease
por: Liu, Hui, et al.
Publicado: (2014)

Epigenetic basis of Alzheimer disease
por: Tecalco-Cruz, Angeles C, et al.
Publicado: (2020)

EPIGENETIC PROFILES OF ALZHEIMER’S DISEASE
por: Thrush, Kyra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c3ceph2c5hkk2vgvipqpb7j2dl